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Introduction
Refractory epilepsy (RE) is a neurological disease. It affects relatively 20% to 30% 
of epileptic patients. Clinicians commonly cannot determine the response to multiple 
Abstract 
Objective
We aimed to assess the effect of body mass index (BMI) on reducing the risk 
of refractory seizure due to lipoid tissue factors.
Materials & Methods
This matched case-control study, consisted of cases (Patients with refractory 
epilepsy) and controls (Healthy children) referred to 17 Shahrivar Hospital, 
Guilan University of Medical Sciences, Guilan, Iran during 2013-2014. 
Data were gathered by a form including demographic characteristics, type 
of epilepsy, predominant time of epilepsy, therapeutic approach, frequency 
of epilepsy, time of disease onset and anthropometric indices. We measured 
anthropometric indices and transformed them into Z-scores. Data were 
reported by descriptive statistics (mean and standard deviation) and analyzed 
by Pearson correlation coefficient, paired t test and multinomial regression 
analysis test using SPSS 19.
Results
There was no significant difference between sex groups regarding 
anthropometric indices. Generalized and focal types of epilepsies were noted 
on 57.5% and 38.75% of patients, respectively. Daytime epilepsies happened 
in 46.25% of patients and 33.75% noted no predominant time for epilepsies. 
Clinicians indicated poly-therapy for the majority of patients (92.5%). The 
most common onset times for epilepsies were 36-72 months for 32.5% of 
patients. Lower onset time indicated lower frequency of refractory epilepsies. 
Although, there was significant difference between Zheight and predominant 
time of epilepsies but no significant relation was found between types of 
epilepsies and frequency of epilepsies with anthropometric indices. Using 
multivariate regression analysis by backward LR, Zweight and birth weight 
were noted as the predicting factors of refractory epilepsies.
Conclusion 
This effect may be because of leptin. Therefore, researchers recommend 
further investigations regarding this issue in children with epilepsy. 
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phenylketonuria, celiac disease or lactose intolerance) 
and feeding with nasogasteric tube. All cases were 
treated with antiepileptic drugs during the study period. 
After sample size determination, we selected 80 children 
with refractory epilepsy from the Outpatient Clinic of 
Pediatric Neurology and Epilepsy in Rasht, northern of 
Iran, and compared with 80 healthy children without 
epilepsy from the Outpatient Clinic of General Pediatric. 
Informed consent letters were obtained from participants. 
Data were gathered by a form including demographic 
characteristics, type of epilepsy, predominant time of 
epilepsy, therapeutic approach, frequency of epilepsy, 
time of disease onset and anthropometric indices. 
We measured anthropometric indices and transformed 
them into Z-scores. Weight/age (W/A), height/age 
(H/A) and BMI/age (BMI/A) were assessed using 
WHO Anthro Plus software based on the latest WHO 
(2005/2007) growth charts. 
Data were reported by descriptive statistics (mean and 
standard deviation) and analyzed by Pearson correlation 
coefficient, paired t test and multinomial regression 
analysis test using SPSS 19 (Chicago, IL, USA).
Results
Thirty-two girls and 48 boys participated in each group. 
The majority of patients in case and control groups were 
term (67 (83.75%) and 72 (90%), respectively).
There was no significant difference between sex groups 
regarding anthropometric indices Table 1) (P>0.05). 
(Generalized and focal types of epilepsy were noted on 
57.5% and 38.75% of patients, respectively. Daytime 
epilepsy happened in 46.25% of patients. 33.75% 
of cases showed no predominant time for epilepsy. 
Clinicians indicated polytherapy for the majority of 
patients (92.5%). The most common onset times for 
epilepsy were 36-72 months for 32.5% of cases. Results 
showed lower onset time indicated lower frequency of 
refractory epilepsy. Furthermore, the most common 
frequency of epilepsies was 7-8 (86.25%). Although, 
there was significant difference between Zheight and 
predominant time of epilepsy (P<0.05), results showed 
no significant relation between types of epilepsy and 
frequency of epilepsy with anthropometric indices 
(Table 2). 
Clinicians administered sodium valproate, topiramate 
line drug therapies in RE patients (1). Epilepsy might 
accompany with malnutrition and noted as two key 
health problems (1, 2). Malnutrition might be indicated 
due to chronic use of anticonvulsant drugs because they 
may influence food intake and energy metabolism. In 
addition, they can induce vomiting, anorexia and feeding 
difficulties in chewing or swallowing. Moreover, their 
energy requirement may be changed according to 
the impedance of the disabilities with their common 
activities (3). 
One of the most common adverse outcomes consequent 
of using anticonvulsants is the weight gain, although, 
recent investigations noted body weight gain as a result 
of consuming valproic acid vigabatrin, gabapentin 
and carbamazepine (4). Yet, there are two different 
hypotheses, which cause a vicious circle: malnutrition 
predisposes epilepsy or epilepsy predisposes malnutrition. 
As malnutrition can be prevented and treated, therefore, 
a thorough understanding of these interactions can be 
recommended (5). On the other hand, in animal model, 
the threshold of epilepsy was changed dramatically by 
neuropeptides especially in hippocampus (6, 7). Obesity 
is noted as the leading factor for maladaptive processes 
for exacerbating chronic diseases such as epilepsy, 
multiple sclerosis and Alzheimer’s disease (6, 8). On the 
other hand, enough endocrine products such as leptin by 
adipose tissue are effective in epilepsy (9, 10). 
The aim of the present study was to evaluate body 
mass index (BMI) and nutritional status in children 
with refractory epilepsy. Anthropometric evaluation 
can easily detect malnutrition; therefore, the results of 
this study might help to improve the treatment. It can 
be regarded for further researches in children with 
refractory epilepsy.
Materials & Methods
This case–control study consisted of cases (Patients 
with refractory epilepsy) and control (healthy children) 
referred to 17 Shahrivar Hospital, Guilan University 
of Medical Sciences, Guilan, Iran during 2013-2014 
.Groups were matched for age, geographical area, 
social and economical status. We excluded children 
with nutritional status impairment (Neoplasia, chronic 
infections), changes in energy metabolism (Hyper-
hypothyroidism), treated with special diets (Diabetes, 
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the patients’ treatment.
Our samples had lower adipose tissues and were thinner, 
which might be because of hormones’ discharge from 
adipose cells such as leptin (16) that may decrease the 
threshold of epilepsies. Therefore, we recommend 
assessing hormones in these patients. However, leptin 
receptor activation, may have potential effect on 
anticonvulsants in emergency situations (9).
Our results showed that increased birth weight reduced 
epilepsies threshold, which was consistent with the 
results mentioned previously (17, 18). However, Rocca 
et al. indicated no significant relation between low birth 
weight and the occurrence of epilepsy (19).
We found no significant difference between Zweight 
in monotherapy and polytherapy and we could not 
determine the role of single treatment with topiramate 
in patients. However, previous investigation noted lower 
weight by administering topiramate (20). 
In conclusion, deciding appropriate programs to 
improve the nutritional status in children with epilepsy 
are recommended. We recommend further investigations 
regarding this issue in children with epilepsy. 
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and priidone for most of the patients (73.75%, 35%, and 
23.75%, respectively). 
In addition, all predicting factors of resistant epilepsy 
with the significant relation (P<0.10) included in 
multivariate regression analysis by backward LR. In 
final model, Zweight and birth weight were determined 
as the predicting factors of refractory epilepsy (Table 3).
Discussion
In this study, we compared anthropometric indices in 
children with epilepsy and healthy children. Although, 
there was no significant difference between groups 
regarding height and weight but significant decreases on 
BMI, Z H/A, Zw/A and Z BMI/A were noted in children 
with epilepsy. 
Decreased Z-scores for H/A in this study was the same 
with the results mentioned by Gutheil et al. (11), that 
the refractory epilepsy might impair growth during 
childhood. However, they did not mention decreased 
BMI, Zw/A and ZBMI/A (11).
It seems that abnormal linear growth is noted because 
of consuming anticonvulsant drugs and their significant 
effect on growth hormone concentrations but in a study, 
normal linear growth was noted (12). Our results showed 
significant relation between Zheight and the time of 
epilepsy. Epilepsies happened more frequently during 
nighttime. This might be because of growth hormone 
production at night, where these patients encounter with 
lower discharge of growth hormone.
In our study, BMI in epileptic patients were less and 
there was significant relation between ZBMI and 
epilepsy. Malnutrition might decrease the threshold of 
epilepsy, but, more evaluation by supporting evidences 
from animal researches and epidemiological findings 
are necessary (13). Furthermore, similar to our results, 
Crepin et al. and Bertoli et al. observed greater risk of 
malnutrition in children with epilepsy than in the control 
group. They noted significant association between 
epilepsy and low BMI (3, 14). This may be because of 
tropical infectious diseases in which similar previous 
results showed that parasitic infections could invade 
the central nervous system and cause neurological 
conditions such as epilepsy (15). Therefore, it seems 
that further assessment regarding tropical diseases in 
patients with epilepsies can be recommended to enhance 
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Table 1. Anthropometric Indices in Groups
Variables








Age (mo) 98.64 30.58 99.14 30.32 P=0.92
Weight (kg) 29.06 11.00 31.79 10.87 P=0.12
height (cm) 128.66 15.32 131.02 16.18 P=0.34
BMI (kg/m2) 16.90 2.97 17.92 2.87 P=0.03
Z W/A* 0.17 0.97 0.78 0.98 0.001
Z H/A** 0.09 0.97 0.43 0.85 0.017
Z BMI/A*** 0.18 1.20 0.69 1.07 0.005
Birth weight(kg) 3.043 0.487 3.616 3.292 P=0.000
Birth height 49.02 2.48 49.88 1.49 P=0.009
*Z W/A: Z-score for weight-for-age; 
**Z H/A: Z-score for height-for-age;
***Z BMI/A: Z-score for body mass index for age




















































































































*Z W/A: Z-score for weight-for-age; 
**Z H/A: Z-score for height-for-age;
***Z BMI/A: Z-score for body mass index for age
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Sex 0.039 0.366 0.916 1.039 0.507 2.13
Age -0.003 0.008 0.742 0.997 0.981 1.014
Zweight/A -0.37 0.745 0619 0.691 0.161 2.973
Zheight/A -0.011 0.452 0.981 0.989 0.408 2.398
Birth weight -0.002 0.001 0.006 0.998 0.996 0.999
Birth height 0.156 0.176 0.376 1.169 0.827 1.652
Gestational age -0.982 1.092 0.369 0.375 0.044 3.185
ZBMI/A -0.707 0.529 0.181 0.493 0.175 1.391
BMI 0.23 0.173 0.183 1.259 0.897 1.767
Constant -2.85 7.724 0.712 0.058
Final model
Zweight/A -0.549 0.18 0.002 0.578 0.406 0.823
Birth weight -0.001 0 0.002 0.999 0.998 0.999
Constant 4.484 1.386 0.001 88.617
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